A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro. (Record no. 28118602)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01841 a2200565 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517202753.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201809s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1879-0712 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/j.ejphar.2018.02.029 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ren, Tong |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180910 |
| 245 00 - TITLE STATEMENT | |
| Title | A novel PPARα/γ agonist, propane-2-sulfonic acid octadec-9-enyl-amide, ameliorates insulin resistance and gluconeogenesis in vivo and vitro. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | European journal of pharmacology |
| Date of publication, distribution, etc. | May 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1-8 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diabetes Mellitus, Experimental |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diabetes Mellitus, Type 2 |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Diet, High-Fat |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dyslipidemias |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Gluconeogenesis |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hep G2 Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Insulin Resistance |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lipid Metabolism |
| General subdivision | drug effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, Inbred C57BL |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | PPAR alpha |
| General subdivision | agonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | PPAR gamma |
| General subdivision | agonists |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Streptozocin |
| General subdivision | toxicity |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sulfonic Acids |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Transcriptional Activation |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yang, Wu-Shuang |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lin, Yi |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Jin-Feng |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Li, Ying |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yang, Li-Chao |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zeng, Kai-Yue |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Peng, Lu |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Liu, Yi-Jun |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ye, Zhen-Hong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Luo, Xiu-Mei |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ke, Yu-Jie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Diao, Yong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jin, Xin |
| 773 0# - HOST ITEM ENTRY | |
| Title | European journal of pharmacology |
| Related parts | vol. 826 |
| -- | p. 1-8 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.ejphar.2018.02.029">https://doi.org/10.1016/j.ejphar.2018.02.029</a> |
| Public note | Available from publisher's website |
No items available.